These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 32181692)

  • 1. Combined Molecular and Phenotypic Antimicrobial Susceptibility Testing Is Beneficial in Detection of ESBL and AmpC Beta-Lactamase Producing Isolates of Enterobacteriaceae in Pediatric Patients with Bloodstream Infections.
    Powell EA; Khalil N; DeBurger B; Mortensen JE
    Microb Drug Resist; 2020 Jul; 26(7):825-830. PubMed ID: 32181692
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenotypic detection of AmpC β-lactamases, extended-spectrum β-lactamases and metallo-β-lactamases in Enterobacteriaceae using a resazurin microtitre assay with inhibitor-based methods.
    Teethaisong Y; Eumkeb G; Chumnarnsilpa S; Autarkool N; Hobson J; Nakouti I; Hobbs G; Evans K
    J Med Microbiol; 2016 Oct; 65(10):1079-1087. PubMed ID: 27481506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of ESBL among AmpC producing enterobacteriaceae using inhibitor-based method.
    Bakthavatchalu S; Shakthivel U; Mishra T
    Pan Afr Med J; 2013; 14():28. PubMed ID: 23504148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S; Gaind R; Ranjan R; Deb M
    J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
    Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and molecular characteristics of ESBL and AmpC β -lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt.
    Mohamed ES; Khairy RMM; Abdelrahim SS
    Antimicrob Resist Infect Control; 2020 Dec; 9(1):198. PubMed ID: 33303028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates.
    Hombach M; Mouttet B; Bloemberg GV
    J Antimicrob Chemother; 2013 Sep; 68(9):2092-8. PubMed ID: 23633681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid-Mediated AmpC β-Lactamase and Underestimation of Extended-Spectrum β-Lactamase in Cefepime-Susceptible Elevated-Ceftazidime-MIC Enterobacteriaceae Isolates.
    Nishimura F; Morinaga Y; Akamatsu N; Matsuda J; Kaku N; Takeda K; Uno N; Kosai K; Hasegawa H; Yanagihara K
    Jpn J Infect Dis; 2018 Jul; 71(4):281-285. PubMed ID: 29709981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and genotypic distribution of ESBL, AmpC β-lactamase and carbapenemase-producing Enterobacteriaceae in community-acquired and hospital-acquired urinary tract infections in Sri Lanka.
    Perera PDVM; Gamage S; De Silva HSM; Jayatilleke SK; de Silva N; Aydin A; Enne VI; Corea EM
    J Glob Antimicrob Resist; 2022 Sep; 30():115-122. PubMed ID: 35667644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique.
    Estaleva CEL; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Simonsen GS; Haldorsen B; Essack SY; Sundsfjord A
    BMC Infect Dis; 2021 Jan; 21(1):16. PubMed ID: 33407206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand.
    Karkaba A; Grinberg A; Benschop J; Pleydell E
    N Z Vet J; 2017 Mar; 65(2):105-112. PubMed ID: 27973988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
    Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of extended-spectrum beta-lactamases and its correlation with clinical laboratory standards institute interpretive criteria for disk diffusion susceptibility testing in enterobacteriaceae isolates in Thaialnd.
    Tangkoskul T; Tiengrim S; Onsomang S; Pati N; Aswapokee N; Thamlikitkul V; Chayakulkeeree M
    Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1461-9. PubMed ID: 23413710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Molecular and Phenotypic Methods for the Detection and Characterization of Carbapenem Resistant Enterobacteriaceae.
    Somily AM; Garaween GA; Abukhalid N; Absar MM; Senok AC
    Acta Microbiol Immunol Hung; 2016 Mar; 63(1):69-81. PubMed ID: 27020870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.
    Tello M; Ocejo M; Oporto B; Hurtado A
    Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32471914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence, Identification, and Antimicrobial Resistance Profiles of Extended-Spectrum and AmpC β-Lactamase-Producing
    Richter L; Du Plessis EM; Duvenage S; Korsten L
    Foodborne Pathog Dis; 2019 Jun; 16(6):421-427. PubMed ID: 30785775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases.
    Poulou A; Grivakou E; Vrioni G; Koumaki V; Pittaras T; Pournaras S; Tsakris A
    J Clin Microbiol; 2014 May; 52(5):1483-9. PubMed ID: 24574283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for Enterobacteriaceae.
    Bork JT; Heil EL; Leekha S; Fowler RC; Hanson ND; Majumdar A; Johnson JK
    Diagn Microbiol Infect Dis; 2017 Dec; 89(4):328-333. PubMed ID: 29031525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia.
    Vlieghe ER; Huang TD; Phe T; Bogaerts P; Berhin C; De Smet B; Peetermans WE; Jacobs JA; Glupczynski Y
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1223-9. PubMed ID: 25717021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.